Stay updated on SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.

Latest updates to the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe release notes footer now shows Revision: v3.6.5, replacing v3.6.4, indicating a small build update. This change does not alter the study details or how the page functions.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page shows Revision: v3.6.4, replacing v3.6.3, indicating a small update to the page's metadata.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a minor system update. No study content or key information appears to be altered.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision upgraded from v3.6.0 to v3.6.2, indicating a newer build of the page. No study-related content or functionality appears to be altered by this update.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page now includes a recruitment status notice indicating no further participant recruitment, and adds helpful guidance links such as How to Read a Study Record, Common Questions, and How to Join a Study. Additionally, the Intervention/Treatment label formatting is adjusted and the site revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check85 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, signaling a minor page build update. No study content or user-facing details are affected by this change.SummaryDifference0.1%

Stay in the know with updates to SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.